EU Explains Safety Reporting Under New Clinical Trial Regs
Executive Summary
An updated guidance document on the EU Clinical Trials Regulation has been published, with new information regarding the requirements for reporting safety issues in clinical trials. The European Medicines Agency says progress with developing the new clinical trial information system is going well but some more enhancements are needed.
You may also be interested in...
EU Finalizes Rules For Coordinated Trial Safety Assessment Under CTR
A new implementing regulation provides a legal basis for EU member states to cooperate on the assessment of trial-related safety reports linked to an active substance instead of the investigational medicinal product.
EMA Reports Progress with EU Clinical Trial & Orphan IT Systems
The European Medicines Agency says progress is being made with new IT systems for clinical trial and orphan designation applications in the EU.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.